Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Biocon climbs on unit's deal for branded formulations business

** Shares of Biocon  BION.NS  settles 5.8% higher at 267.40
rupees  
    ** Unit Biocon Biologics to transfer branded formulations
business in India to Eris Lifesciences  ERIS.NS  in a 12.42 bln
rupees ($150 mln) deal
    ** BION rose as much as 8.2% after the announcement
    ** ERIS settled 3.8% higher 
    ** BION up ~7% YTD, vs a ~12% rise in Nifty Pharma index
 .NIPHARM 
 
 ($1 = 82.8170 Indian rupees)

 (Reporting by Nishit Navin)
 ((nishit.navin@thomsonreuters.com;))

Recent news on Eris Lifesciences

See all news